Alzheimer’s Disease Drug to be Discontinued Forest Laboratories announced its plan to continue marketing both the Namenda (memantine HCl) 5mg and 10mg tablets, and Namenda XR (memantine HCl) ...
Forest Laboratories announced today that the company will discontinue sale of memantine (Namenda) 5-mg and 10-mg tablets effective August 15, 2014, in favor of focusing on sales of its once-daily ...
Alzheimer’s Disease Drug to be Discontinued Forest Laboratories announced its plan to discontinue the sale of Namenda 5mg and 10mg tablets on August 15, 2014. Forest Laboratories announced its plan to ...
DUBLIN, May 22, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S. Court of Appeals for the Second Circuit has issued a ruling upholding a December 15, 2014 ...
MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its ...
Namenda (memantine) can cause side effects that range from mild to serious. More common side effects include dizziness and headache. If side effects from Namenda become difficult to tolerate, talk ...
Namenda (memantine) is a prescription drug that’s used to treat dementia related to Alzheimer’s disease. This drug can interact with other medications and some supplements. For example, Namenda can ...
MUMBAI--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary a tentative approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results